Literature DB >> 918585

[Paraneoplastic eosinophilic leukemoid with eosinophilic parietal thromboendocarditis in malignant melanoma].

R Siebenschein, R E Siebenmann.   

Abstract

A case of an eosinophilic leukemoid reaction associated with metastasizing malignant melanoma and thrombotic eosinophilic parietal endocarditis in a 58-year-old white male is reported. No similar cases were found in the literature. The leukemoid reaction with leukocytosis of up to 102 300 white cells per microliter , 65% of which were eosinophils, was observed during the last two months of life of the patient, who died of multiple metastasis of malignant melanoma. The primary malignant melanoma had been excised four years before death. The parietal endocarditis was localized on the posterior wall of the left ventricle and was found incidentally at autopsy. The association of leukemoid eosinophilic reaction with consecutive eosinophilic thrombotic parietal endocarditis is believed to be part of a paraneoplastic syndrome. 63 published cases of paraneoplastic eosinophilic leukemoid reaction and 6 published cases of malignant tumor with eosinophilia and additional parietal endocarditis were found. The pathogenesis of these conditions is discussed.

Entities:  

Mesh:

Year:  1977        PMID: 918585

Source DB:  PubMed          Journal:  Schweiz Med Wochenschr        ISSN: 0036-7672


  4 in total

Review 1.  Primary malignant melanoma of the gall bladder.

Authors:  D I Heath; C Womack
Journal:  J Clin Pathol       Date:  1988-10       Impact factor: 3.411

2.  The pathogenesis of eosinophilic endomyocardial disease in patients with carcinomas of the lung.

Authors:  C J Spry; A P Weetman; I Olsson; P C Tai; E G Olsen
Journal:  Heart Vessels       Date:  1985-08       Impact factor: 2.037

3.  Paraneoplastic eosinophilia in malignant melanoma.

Authors:  S A Rule; P Waterhouse; C Costello; S Retsas
Journal:  J R Soc Med       Date:  1993-05       Impact factor: 18.000

4.  Hypereosinophilia in Solid Tumors-Case Report and Clinical Review.

Authors:  Ewa Zalewska; Łukasz Obołończyk; Krzysztof Sworczak
Journal:  Front Oncol       Date:  2021-03-24       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.